ISO 14971 Risk Management

ISO 14971 Medical Device Risk Management Application Throughout Lifecycle

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Systematic explanation of ISO 14971 risk management planning, hazard identification, risk assessment, and design controls verification, including dFMEA and pFMEA.

Key answer

ISO 14971 guides medical device manufacturers to identify hazards, estimate and evaluate associated risks, and implement mitigation controls to reach acceptable levels. The core deliverables include the Risk Management Plan (RMP), Risk Management Report (RMR), Hazard Analysis table, and Failure Mode and Effects Analysis (FMEA).

Difference Between Hazard Analysis and FMEA

Hazard Analysis acts at a high level, identifying hazards caused by design, materials, software, or user error (e.g., "electrical shock," "microbial contamination"). FMEA is an engineering failure analysis tool (dFMEA for design failures, pFMEA for process failures, e.g., "low injection mold temperature causing part weakness"). They are complementary but distinct.

  • Hazard analysis focuses on defining risk acceptability using a severity-occurrence matrix
  • FMEA analyzes component and process failure modes, applying mitigation or detection controls
  • Residual risk evaluation: verifying if mitigation controls introduce new hazards or risks

FAQ

What is a Residual Risk Assessment?+

After implementing risk control measures, the remaining risk is the individual residual risk. After all controls are implemented, the manufacturer must evaluate the overall residual risk to ensure clinical benefits outweigh it.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.